GC Lipid

About GC Lipid

GC Lipid, now operating as SEVO Bioscience, is a biotechnology company focused on creating sustainable solutions for the aquaculture feed industry. The company was co-founded by CEO Brandon Serrasan and CSO Dylan Deska-Gauthier. Their journey began at the District 3 accelerator in 2020, progressing through the Validation, Launch, and Grow programs, which provided crucial support in developing their business plan and connecting with industry partners.

The core of the company's business is to address the unsustainable practice of using wild-caught fish for fishmeal and fish oil in aquaculture. Approximately 25% of all wild-caught fish are used for this purpose, putting significant strain on marine ecosystems. GC Lipid's solution is a superior-quality fish feed derived from genetically engineered microalgae. This approach aims to replace traditional fishmeal, thereby reducing overfishing and its ecological impact. The company operates in the cleantech and biotech sectors, specifically targeting aquaculture farms as its primary clients.

The company's technology is rooted in synthetic biology. By re-engineering the natural metabolic pathways in microalgae, they can produce a commercially viable and sustainable supply of lipids essential for fish health and, ultimately, human health. The scientific focus involves creating a diverse portfolio of genetically engineered microalgae strains. This allows them to tailor the feed's nutritional profile to the specific dietary requirements of different fish species, opening up various market segments. A significant part of their development process involves scaling up production from the lab to industrially relevant quantities, for which they leverage partnerships with contract manufacturing organizations (CMOs) to access the necessary facilities and expertise.